Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Incyte Corp (INCY)

Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,132,539
  • Shares Outstanding, K 193,524
  • Annual Sales, $ 4,241 M
  • Annual Income, $ 32,610 K
  • EBIT $ 61 M
  • EBITDA $ 151 M
  • 60-Month Beta 0.76
  • Price/Sales 3.09
  • Price/Cash Flow 122.31
  • Price/Book 3.78

Options Overview Details

View History
  • Implied Volatility 53.77% ( -3.79%)
  • Historical Volatility 36.16%
  • IV Percentile 94%
  • IV Rank 78.21%
  • IV High 63.71% on 03/11/25
  • IV Low 18.10% on 05/16/24
  • Put/Call Vol Ratio 0.01
  • Today's Volume 1,769
  • Volume Avg (30-Day) 1,586
  • Put/Call OI Ratio 0.31
  • Today's Open Interest 38,343
  • Open Int (30-Day) 37,191

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.73
  • Number of Estimates 5
  • High Estimate 0.96
  • Low Estimate 0.52
  • Prior Year 0.38
  • Growth Rate Est. (year over year) +92.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
66.37 +2.24%
on 03/12/25
76.24 -10.99%
on 02/25/25
-2.56 (-3.64%)
since 02/14/25
3-Month
65.56 +3.51%
on 02/12/25
76.96 -11.82%
on 02/07/25
-0.69 (-1.01%)
since 12/13/24
52-Week
50.35 +34.78%
on 04/30/24
83.95 -19.17%
on 11/08/24
+9.32 (+15.92%)
since 03/14/24

Most Recent Stories

More News
LLY/INCY Olumiant Shows Superior Efficacy in Pediatric Alopecia Study

Eli Lilly LLY and partner Incyte INCY announced that a late-stage study evaluating oral baricitinib in adolescent patients (aged 12-18) with severe alopecia areata (AA) showed clinically meaningful improvements...

BMRN : 69.44 (-1.64%)
LLY : 813.48 (+1.48%)
INCY : 67.86 (+0.22%)
GILD : 111.44 (-1.69%)
Is Regeneron Pharmaceuticals Stock Underperforming the Dow?

Regeneron Pharmaceuticals has underperformed the Dow over the past year, but analysts are highly optimistic about the stock’s prospects.

INCY : 67.86 (+0.22%)
$DOWI : 41,488.19 (+1.65%)
REGN : 666.87 (-2.02%)
Exact Sciences (EXAS) Reports Earnings Tomorrow: What To Expect

Exact Sciences (EXAS) Reports Earnings Tomorrow: What To Expect

EXAS : 45.00 (+4.55%)
INCY : 67.86 (+0.22%)
REGN : 666.87 (-2.02%)
Are Wall Street Analysts Bullish on Incyte Stock?

Incyte has continued to observe strong demand for Jakafi and Opzelura, leading to robust growth in sales, and analysts remain bullish on the stock’s prospects.

$SPX : 5,638.94 (+2.13%)
INCY : 67.86 (+0.22%)
XBI : 87.13 (+1.35%)
2 ‘Strong Buy’ Growth Stocks Poised for 141% to 193% Gains, According to Wall Street

The recent advancements in their pipelines imply high growth potential in the coming years.

ZVRA : 8.31 (+4.66%)
RPRX : 32.77 (+0.28%)
SNDX : 12.95 (-1.15%)
INCY : 67.86 (+0.22%)
Stock market today: Wall Street takes Trump's latest tariff threats in stride, and indexes rise

U.S. stock indexes rose as Wall Street took President Donald Trump’s latest threat on tariffs in stride

AA : 33.53 (+3.78%)
NVDA : 121.67 (+5.27%)
AVGO : 195.54 (+2.18%)
$SPX : 5,638.94 (+2.13%)
GM : 48.34 (+2.61%)
MS : 115.34 (+3.28%)
$IUXX : 19,704.64 (+2.49%)
MCD : 299.83 (+0.78%)
INCY : 67.86 (+0.22%)
$DOWI : 41,488.19 (+1.65%)
CLF : 10.39 (+6.78%)
AMZN : 197.95 (+2.09%)
Stocks Settle Higher and Brush Aside Tariff Concerns

The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.67%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.38%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.24%. March E-mini S&P...

AMAT : 155.66 (+3.81%)
AVGO : 195.54 (+2.18%)
KHC : 30.23 (+0.13%)
$IUXX : 19,704.64 (+2.49%)
ASML : 714.00 (+2.79%)
AXSM : 121.91 (+0.21%)
ZNM25 : 110-205s (-0.27%)
SHOP : 94.85 (+4.70%)
MNDY : 255.87 (+5.57%)
RHI : 53.08 (+2.16%)
ESH25 : 5,640.00s (+2.04%)
QCOM : 156.58 (+3.05%)
Why Incyte (INCY) Shares Are Plunging Today

Why Incyte (INCY) Shares Are Plunging Today

INCY : 67.86 (+0.22%)
Stocks Push Higher on Strength in Metal Producers and Chip Stocks

The S&P 500 Index ($SPX ) (SPY ) today is up +0.73%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.27%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.35%. March E-mini S&P futures (ESH25...

AMAT : 155.66 (+3.81%)
AVGO : 195.54 (+2.18%)
$IUXX : 19,704.64 (+2.49%)
ASML : 714.00 (+2.79%)
AXSM : 121.91 (+0.21%)
ZNM25 : 110-205s (-0.27%)
SHOP : 94.85 (+4.70%)
NTAP : 91.98 (+2.13%)
MNDY : 255.87 (+5.57%)
RHI : 53.08 (+2.16%)
ESH25 : 5,640.00s (+2.04%)
QCOM : 156.58 (+3.05%)
Stocks See Support from Metal Producers after Trump Slaps Tariffs on Steel and Aluminum

The S&P 500 Index ($SPX ) (SPY ) today is up +0.39%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.87%. March E-mini S&P futures (ESH25...

$IUXX : 19,704.64 (+2.49%)
AXSM : 121.91 (+0.21%)
ZNM25 : 110-205s (-0.27%)
SHOP : 94.85 (+4.70%)
NTAP : 91.98 (+2.13%)
MNDY : 255.87 (+5.57%)
RHI : 53.08 (+2.16%)
ESH25 : 5,640.00s (+2.04%)
CMC : 46.34 (+4.16%)
X : 39.00 (+3.94%)
$DOWI : 41,488.19 (+1.65%)
SPY : 562.81 (+2.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Incyte Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. The company conducts its European clinical development operations in Geneva, Switzerland. Incyte's lead drug, Jakafi (ruxolitinib), is a first-in-class JAK1/JAK2...

See More

Key Turning Points

3rd Resistance Point 69.13
2nd Resistance Point 68.63
1st Resistance Point 68.24
Last Price 67.86
1st Support Level 67.35
2nd Support Level 66.85
3rd Support Level 66.46

See More

52-Week High 83.95
Fibonacci 61.8% 71.11
Last Price 67.86
Fibonacci 50% 67.15
Fibonacci 38.2% 63.19
52-Week Low 50.35

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar